Disseminated and circulating tumor cells: Role in effective cancer management

Henry Lin, Marija Balic, Siyang Zheng, Ram Datar, Richard J Cote

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Dissemination of tumor cells from primary tumors in the circulatory system is an early event in carcinogenesis. The presence of these single disseminated tumor cells (DTC) in peripheral blood, bone marrow and distant organs is the rationale for adjuvant systemic treatment. Detection of DTC in bone marrow aspirates from breast cancer patients and other solid tumors at the primary diagnosis impacts the prognosis of disease. In peripheral blood these cells are termed as circulating tumor cells (CTC). Due to technical difficulties the clinical significance of CTC detection at early stages is less established. This review focuses on available techniques for detection of DTC and CTC, recent technical advances in development of more sensitive microfluidic methods for capture of DTC and CTC and possibilities for further detection and their potential molecular characterization. Not only the clinical significance of DTC but also the presence of cancer stem cells in dissemination clearly demonstrates the need for development of sensitive technologies allowing for definition of biomarkers and molecular targets on cells in dissemination, thus eventually leading to optimization of systemic therapies.

Original languageEnglish
Pages (from-to)1-11
Number of pages11
JournalCritical Reviews in Oncology/Hematology
Volume77
Issue number1
DOIs
StatePublished - Jan 1 2011

Fingerprint

Circulating Neoplastic Cells
Neoplasms
Microfluidics
Neoplastic Stem Cells
Cardiovascular System
Bone Marrow Cells
Blood Cells
Carcinogenesis
Biomarkers
Bone Marrow
Breast Neoplasms
Technology

Keywords

  • Characterization
  • Circulating tumor cells
  • Detection
  • Disseminated tumor cells
  • Enrichment

ASJC Scopus subject areas

  • Oncology
  • Hematology
  • Geriatrics and Gerontology

Cite this

Disseminated and circulating tumor cells : Role in effective cancer management. / Lin, Henry; Balic, Marija; Zheng, Siyang; Datar, Ram; Cote, Richard J.

In: Critical Reviews in Oncology/Hematology, Vol. 77, No. 1, 01.01.2011, p. 1-11.

Research output: Contribution to journalArticle

Lin, Henry ; Balic, Marija ; Zheng, Siyang ; Datar, Ram ; Cote, Richard J. / Disseminated and circulating tumor cells : Role in effective cancer management. In: Critical Reviews in Oncology/Hematology. 2011 ; Vol. 77, No. 1. pp. 1-11.
@article{4d7a8a1a0e594dcba8e134637e9112f6,
title = "Disseminated and circulating tumor cells: Role in effective cancer management",
abstract = "Dissemination of tumor cells from primary tumors in the circulatory system is an early event in carcinogenesis. The presence of these single disseminated tumor cells (DTC) in peripheral blood, bone marrow and distant organs is the rationale for adjuvant systemic treatment. Detection of DTC in bone marrow aspirates from breast cancer patients and other solid tumors at the primary diagnosis impacts the prognosis of disease. In peripheral blood these cells are termed as circulating tumor cells (CTC). Due to technical difficulties the clinical significance of CTC detection at early stages is less established. This review focuses on available techniques for detection of DTC and CTC, recent technical advances in development of more sensitive microfluidic methods for capture of DTC and CTC and possibilities for further detection and their potential molecular characterization. Not only the clinical significance of DTC but also the presence of cancer stem cells in dissemination clearly demonstrates the need for development of sensitive technologies allowing for definition of biomarkers and molecular targets on cells in dissemination, thus eventually leading to optimization of systemic therapies.",
keywords = "Characterization, Circulating tumor cells, Detection, Disseminated tumor cells, Enrichment",
author = "Henry Lin and Marija Balic and Siyang Zheng and Ram Datar and Cote, {Richard J}",
year = "2011",
month = "1",
day = "1",
doi = "10.1016/j.critrevonc.2010.04.008",
language = "English",
volume = "77",
pages = "1--11",
journal = "Critical Reviews in Oncology/Hematology",
issn = "1040-8428",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Disseminated and circulating tumor cells

T2 - Role in effective cancer management

AU - Lin, Henry

AU - Balic, Marija

AU - Zheng, Siyang

AU - Datar, Ram

AU - Cote, Richard J

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Dissemination of tumor cells from primary tumors in the circulatory system is an early event in carcinogenesis. The presence of these single disseminated tumor cells (DTC) in peripheral blood, bone marrow and distant organs is the rationale for adjuvant systemic treatment. Detection of DTC in bone marrow aspirates from breast cancer patients and other solid tumors at the primary diagnosis impacts the prognosis of disease. In peripheral blood these cells are termed as circulating tumor cells (CTC). Due to technical difficulties the clinical significance of CTC detection at early stages is less established. This review focuses on available techniques for detection of DTC and CTC, recent technical advances in development of more sensitive microfluidic methods for capture of DTC and CTC and possibilities for further detection and their potential molecular characterization. Not only the clinical significance of DTC but also the presence of cancer stem cells in dissemination clearly demonstrates the need for development of sensitive technologies allowing for definition of biomarkers and molecular targets on cells in dissemination, thus eventually leading to optimization of systemic therapies.

AB - Dissemination of tumor cells from primary tumors in the circulatory system is an early event in carcinogenesis. The presence of these single disseminated tumor cells (DTC) in peripheral blood, bone marrow and distant organs is the rationale for adjuvant systemic treatment. Detection of DTC in bone marrow aspirates from breast cancer patients and other solid tumors at the primary diagnosis impacts the prognosis of disease. In peripheral blood these cells are termed as circulating tumor cells (CTC). Due to technical difficulties the clinical significance of CTC detection at early stages is less established. This review focuses on available techniques for detection of DTC and CTC, recent technical advances in development of more sensitive microfluidic methods for capture of DTC and CTC and possibilities for further detection and their potential molecular characterization. Not only the clinical significance of DTC but also the presence of cancer stem cells in dissemination clearly demonstrates the need for development of sensitive technologies allowing for definition of biomarkers and molecular targets on cells in dissemination, thus eventually leading to optimization of systemic therapies.

KW - Characterization

KW - Circulating tumor cells

KW - Detection

KW - Disseminated tumor cells

KW - Enrichment

UR - http://www.scopus.com/inward/record.url?scp=78650307932&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650307932&partnerID=8YFLogxK

U2 - 10.1016/j.critrevonc.2010.04.008

DO - 10.1016/j.critrevonc.2010.04.008

M3 - Article

C2 - 20570170

AN - SCOPUS:78650307932

VL - 77

SP - 1

EP - 11

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

IS - 1

ER -